Citation Impact
Citing Papers
The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia
2011 Standout
Predictors of Postoperative Pain and Analgesic Consumption
2009 Standout
Efficacy of Intravenous Immunoglobulin Combined with Prednisolone Following Resistance to Initial Intravenous Immunoglobulin Treatment of Acute Kawasaki Disease
2013
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Psychological therapies for the management of chronic pain (excluding headache) in adults
2012 Standout
Long‐term efficacy of plasma exchange treatment for refractory Kawasaki disease
2011
Intra-articular treatment of hip osteoarthritis: a randomized trial of hyaluronic acid, corticosteroid, and isotonic saline
2005
Patients with juvenile psoriatic arthritis comprise two distinct populations
2006
Abdominal obesity and metabolic syndrome
2006 StandoutNature
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
2003 Standout
Subtyping of juvenile idiopathic arthritis using latent class analysis
2000
A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura
2008
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features
2015 Standout
Long‐term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis
2009
The metabolic syndrome
2010 Standout
Systematic review of randomised controlled trials of psychological therapy for chronic pain in children and adolescents, with a subset meta-analysis of pain relief
2002
Juvenile idiopathic arthritis
2007 Standout
Visits to Complementary and Alternative Medicine Providers by Children and Adolescents in the United States
2004
Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin
2011
Epidemiology of Osteoarthritis
2010 Standout
Myositis-specific autoantibodies: their clinical and pathogenic significance in disease expression
2009
Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients
2002
“Listening” and “talking” to neurons: Implications of immune activation for pain control and increasing the efficacy of opioids
2007
Use of Complementary and Alternative Medicine by Children in the United States
2003
Psoriatic arthritis: epidemiology, clinical features, course, and outcome
2005 Standout
Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy
2005
TFOS DEWS II pathophysiology report
2017 Standout
Pediatric Rheumatology in Southeast Asia: Insights from the Singapore Experience
2010
Chronic pediatric inflammatory diseases: Effects on bone
2007
Osteoarthritis
2015 Standout
Clinical Significance of the Antinuclear Antibody Test in Selected Children with Idiopathic Thrombocytopenic Purpura
1997
Alternative and complementary therapy use in pediatric oncology patients in British Columbia: prevalence and reasons for use and nonuse.
1998
Genetic predictors of acute and chronic pain
2006
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): A retrospective study
2011 Standout
Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects
2002
TFOS DEWS II Epidemiology Report
2017 Standout
The metabolic syndrome
2005 Standout
Lipodystrophies: rare disorders causing metabolic syndrome
2004
Current Status of Pain Management in Children
2003
Inflammatory cytokine profiles during Cyclosporin treatment for immunoglobulin-resistant Kawasaki disease
2012
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
The use of methotrexate in childhood rheumatic diseases
1998
Insulin and insulin resistance:
2004 Standout
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
2020 Standout
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Acquired and Inherited Lipodystrophies
2004
Non‐medical use of prescription stimulants among US college students: prevalence and correlates from a national survey
2004 Standout
Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis
2007
Cytokines, Inflammation, and Pain
2007 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Historical background and epidemiology
1994
Clinical Remission in Patients with Systemic Juvenile Idiopathic Arthritis Treated with Anti-Tumor Necrosis Factor Agents
2009
Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
2013 Standout
Rituximab in the treatment of dermatomyositis: An open‐label pilot study
2005
TRIM28 prevents autoinflammatory T cell development in vivo
2012 StandoutNobel
Polymyositis and dermatomyositis
2003 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Inflammatory muscle diseases
2001
The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism
2010
Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity
2009 Standout
Oral health‐related quality of life in children: Part II. Effects of clinical oral health status. A systematic review
2008
Nociceptors: the sensors of the pain pathway
2010 StandoutNobel
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes
2002
Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain
2006
Role of psychology in pain management
2001
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Evidence‐based guidelines for the use of immunologic tests: Antinuclear antibody testing
2002
Oral Health-related Quality of Life
2011 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.
2004 Standout
Acupuncture: Theory, Efficacy, and Practice
2002 Standout
Psoriasis Pathogenesis and Treatment
2019 Standout
Clinical Characteristics of 58 Children With a Pediatric Inflammatory Multisystem Syndrome Temporally Associated With SARS-CoV-2
2020 Standout
ROLE OF CYTOKINES IN RHEUMATOID ARTHRITIS
1996 Standout
Complementary and Alternative Medicine Use Among Adults and Children: United States, 2007
2008 Standout
Progress in Genetic Studies of Pain and Analgesia
2008
Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis.
2001
Intravenous immunoglobulin plus corticosteroid to prevent coronary artery abnormalities in Kawasaki disease: a meta-analysis
2012
Survey of acupuncturists: practice characteristics and pediatric care.
1999
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Intra-articular corticosteroids are effective in osteoarthritis but there are no clinical predictors of response.
1996
Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism.
2001
Knee osteoarthritis has doubled in prevalence since the mid-20th century
2017 Standout
Evidence-Based Medicine
1992 Standout
In situ immune complex formation and glomerular injury
1980
Simple Linear Regression in Medical Research
1985
The Metabolic Syndrome
2008 Standout
DRUG-INDUCED LUPUS
1994
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
The Biology and Detection of Immune Complexes
1980
Differential expression of cytokines in painful and painless neuropathies
2007
Works of Peter N. Malleson being referenced
Chronic musculoskeletal and other idiopathic pain syndromes
2001
The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis
2002
Clinical and therapeutic aspects of Juvenile-onset spondyloarthropathies
1997
Psoriatic arthritis in children
1989
Cytokine genotypes correlate with pain and radiologically defined joint damage in patients with juvenile rheumatoid arthritis
2005
Radiographic followup of joints injected with triamcinolone hexacetonide for the management of childhood arthritis
1990
Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis
2000
Intestinal pseudo-obstruction as an initial presentation of systemic sclerosis in two children
1997
Seasonal onset of systemic-onset juvenile rheumatoid arthritis
1996
Lipodystrophy in patients with juvenile dermatomyositis--evaluation of clinical and metabolic abnormalities.
2001
Persistent Antinuclear Antibodies in Children Without Identifiable Inflammatory Rheumatic or Autoimmune Disease
1992
Rheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritis.
1997
REACTIVITY OF ANTINUCLEAR ANTIBODIES WITH HISTONES AND OTHER ANTIGENS IN JUVENILE RHEUMATOID ARTHRITIS
1989
Corticosteroid treatment of refractory Kawasaki disease.
2006
Vasculopathy with renal artery stenosis in a child with sarcoidosis
1986
Unconventional Remedies Used for Patients With Juvenile Arthritis
1990
The incidence of pediatric rheumatic diseases: results from the Canadian Pediatric Rheumatology Association Disease Registry.
1996
Autoantibodies in chronic arthritis of childhood: relations with each other and with histocompatibility antigens.
1992
Bone mineral density in children and adolescents with systemic lupus erythematosus, juvenile dermatomyositis, and systemic vasculitis: relationship to disease duration, cumulative corticosteroid dose, calcium intake, and exercise.
2005
Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort.
2002
Circulating Immune Complexes in Steroid-Responsive Nephrotic Syndrome
1978